AstraZeneca chairman repeats their position on investing in UK during Brexit talks, triggering fresh fears
LONDON — With a looming exit from the EU coming up, it’s not hard for any company to spur intense anxiety in the UK …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
